For instance, T1/ST2 exists also as a soluble isoform obtained by differential mRNA processing, which acts as an antagonistic decoy receptor for IL-33 (154), and has been proposed in the therapy of arthritis (155). The gene discussed is IL33; the disease is arthritic joint disease.